Apollo Endosurgery, Inc. (NASDAQ:APEN) Files An 8-K Other EventsItem 8.01Other Events.
As previously disclosed in Apollo Endosurgery, Inc.’s Quarterly Report on Form 10-Q, for the second quarter ended June 30, 2017, in March 2017, we were informed by the Department of Justice that we were a subject in a federal False Claims Act investigation concerning whether there had been a violation of the False Claims Act, 31 U.S.C. §3729 et. seq. related to the marketing of the Lap-Band System, including the web-based physician locator provided on our website Lap-Band.com, which we believe relates to the period before and after our acquisition in December 2013 of the obesity intervention division of Allergan,Inc. We have, and continue to cooperate fully with the investigation, and on August 21, 2017, we were notified by the Department of Justice that we were no longer a subject in such investigation.
Please see the section titled “Risk Factors” in our Quarterly Report on Form 10-Q, for the three months ended June 30, 2017, filed with the Securities and Exchange Commission on August 1, 2017, for a discussion of the risks facing our business.
About Apollo Endosurgery, Inc. (NASDAQ:APEN)
Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company’s products include ORBERA, LAP-BAND and OverStitch. The Company’s product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.